Compare IMTX & UAMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMTX | UAMY |
|---|---|---|
| Founded | N/A | 1968 |
| Country | Germany | United States |
| Employees | 423 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | N/A | 1997 |
| Metric | IMTX | UAMY |
|---|---|---|
| Price | $10.01 | $10.47 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $19.25 | $7.69 |
| AVG Volume (30 Days) | 351.5K | ★ 10.0M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 66.67 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $14,937,962.00 |
| Revenue This Year | N/A | $164.09 |
| Revenue Next Year | $19.39 | $218.34 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 71.84 |
| 52 Week Low | $3.30 | $1.21 |
| 52 Week High | $12.41 | $19.71 |
| Indicator | IMTX | UAMY |
|---|---|---|
| Relative Strength Index (RSI) | 50.18 | 64.90 |
| Support Level | $9.66 | $6.57 |
| Resistance Level | $10.64 | $11.97 |
| Average True Range (ATR) | 0.54 | 0.82 |
| MACD | 0.02 | 0.21 |
| Stochastic Oscillator | 40.23 | 96.35 |
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has two operating segments: antimony and zeolite. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the United States, Canada, and Mexico, of which the vast majority of its revenue comes from the United States.